312
Participants
Start Date
July 31, 2008
Primary Completion Date
March 31, 2011
Study Completion Date
April 30, 2011
emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
FTC 200 mg/TDF 300 mg tablet, once a day
abacavir (ABC)/lamivudine (3TC)
ABC 600 mg/3TC 300 mg tablet, once a day
Ricky K. Hsu, MD, PC, New York
Greiger Clinic, Mount Vernon
AIDS Community Health Center, Rochester
University of Rochester Medical Center, Rochester
Chase Brexton Health Services, Baltimore
Upstate Infectious Diseases Associates, Albany
Wake Forest University School of Medicine, Winston-Salem
East Carolina University The Brody School of Medicine, Greenville
ID Consultants, P.A., Charlotte
Atlanta Infectious Disease Group, PC, Atlanta
Infectious Disease Solutions, Atlanta
Family Healthcare of Atlanta PC, Atlanta
Chatham County Health Department, Savannah
University of Florida, Jacksonville
Infectious Diseases Associates of NW FL, Pensacola
Orlando Immunology Center, Orlando
The Kinder Medical Group, Miami
University of Miami, Miami
Wohlfeiler, Piperato and Associates, LLC, Miami Beach
South Florida Infectious Diseases and Tropical Medicine Center, Miami
Community Health of South Florida Inc., Miami
Biogenomx Research Institute, LLC, Fort Lauderdale
Life Way Inc., Fort Lauderdale
Therafirst Medical Centers, Fort Lauderdale
HIV Clinical Research, Fort Lauderdale
Gary Richmond, MD, PA, Inc., Fort Lauderdale
USF Health, Tampa
Infectious Disease Research Institute, Inc., Tampa
Clinical Pharmacology Services, Tampa
Barry M. Rodwick, M.D., Safety Harbor
Associates in Infectious Diseases, Port Saint Lucie
University of Louisville, Louisville
Summa Health System Care Center, Akron
Be Well Medical Center, Berkley
Henry Ford Hospital, Detroit
St. John Hospital Internal Medicine Clinic - Mack Office Building, Grosse Point Woods
Michigan State University, College of Osteopathic Medicine, East Lansing
Medical College of Wisconsin, Milwaukee
Hennepin County Medical Center, Minneapolis
Abbott Northwestern Hospital, Minneapolis
Howard Brown Health Center, Chicago
NorthStar Medical Center, Chicago
Health For Life Clinic, PLLC, Little Rock
Baylor University Medical Center, Dallas
UT Southwestern Medical Center at Dallas, Dallas
North Texas Inf. Disease Consultants, Dallas
Tarrant County Infectious Disease Associates, Fort Worth
Therapeutic Concepts, PA, Houston
Gordon E. Crofoot, MD, PA, Houston
Valley AIDS Counsel, Harlingen
Central Texas Clinical Research, Austin
Kaiser Permanente, Denver
Jeffrey Goodman Special Care Clinic, Los Angeles
Peter J. Ruane, MD, Inc., Los Angeles
Anthony M Mills, MD, Los Angeles
Vista Medical Partners, Beverly Hills
AHF, Beverly Hills
Pacific Oaks Medical Group, Beverly Hills
Living Hope Clinical Foundation, Long Beach
Tarzana Treatment Center, Northridge
Orange Coast Medical Group, Newport Beach
Center for Special Immunology, Fountain Valley
Health Management Institute, Inc., San Francisco
Metropolis Medical, San Francisco
Alameda County Medical Center, Oakland
Daniel Coulston, MD, Spokane
Blick Medical Associates, Norwalk
MetroWest Medical Center, Framingham
Community Research Initiative of New England - WEST, Springfield
The Research Institute, Springfield
ID Associates, PA, Hillsborough
Saint Michael's Medical Center, Newark
South Jersey Infectious Disease, Somers Point
University of British Columbia, Vancouver
Canadian Immunodeficiency Research Collaborative Incorporated, Toronto
CascAids Research, Toronto
Clinique Du Quartier Latin, Montreal
Instituto de Investigacion Cientifica del Sur, Ponce
Clinical Research Puerto Rico Inc, San Juan
University of Puerto Rico, San Juan
Lead Sponsor
Gilead Sciences
INDUSTRY